Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review

Postgraduate Medicine
Neel MehtaSudhir Diwan

Abstract

Constipation is a common adverse effect in patients requiring long-term opioid therapy for pain control. Methylnaltrexone, a quaternary peripheral mu-opioid receptor antagonist, is an effective treatment of opioid induced constipation (OIC) without affecting centrally mediated analgesia. Our objective was to conduct a review and meta-analysis to evaluate the efficacy of methylnaltrexone for treatment of OIC, as well as to provide a clinical discussion regarding newly developed alternatives and provide the current treatment algorithm utilized at our institution. We performed a systematic review and meta-analysis of randomized control trials using Cochrane Collaboration Databases and MEDLINE from 2007-present. Literature related to methylnaltrexone, opioids, opioid receptors, opioid antagonists, opioid-induced constipation were reviewed. A meta-analysis was completed with the primary outcome of rescue-free bowel movement (RFBM) within four hours of administration. All pooled analyses were based on random-effects models. 1239 patients were analyzed; 599 received methylnaltrexone and 640 received placebo. With a 95% CI calculated, the true risk difference is between 0.267 and 0.385, demonstrating a statistically significant differe...Continue Reading

References

May 30, 2008·The New England Journal of Medicine·Jay ThomasRobert J Israel
Aug 30, 2008·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Timothy J BellRussell Williamson
Jul 23, 2009·Annals of Internal Medicine·David MoherUNKNOWN PRISMA Group
Aug 12, 2009·Journal of Pain & Palliative Care Pharmacotherapy·Sean D CandrilliShrividya Iyer
Jan 22, 2010·The Cochrane Database of Systematic Reviews·Meredith NobleKaren M Schoelles
May 1, 2010·The Journal of Pain : Official Journal of the American Pain Society·C Richard ChapmanConstance M Weisner
Jul 14, 2010·Journal of Pain and Symptom Management·Ann Corken MackeyMark Avigan
Feb 24, 2011·The American Journal of Gastroenterology·Michael Camilleri
Mar 25, 2011·The Journal of Pain : Official Journal of the American Pain Society·Edward MichnaBruce Randazzo
Jul 9, 2011·Journal of the American Board of Family Medicine : JABFM·Lawrence LeungWalter Rosser
Jul 21, 2011·Journal of Anaesthesiology, Clinical Pharmacology·Deepak ThapaVanita Ahuja
Aug 13, 2011·Clinical Medicine Insights. Oncology·S BaderG Becker
Oct 15, 2011·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Lucas AnissianTage Ramakrishna
Jan 18, 2012·Journal of Pain and Symptom Management·Robert TwycrossAndrew Wilcock
Jun 12, 2013·The American Journal of Gastroenterology·Alexander C FordPhilip S Schoenfeld
Jun 5, 2014·The New England Journal of Medicine·William D CheyJan Tack
Sep 15, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Sam H AhmedzaiMichael Hopp
Oct 28, 2014·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·M BlagdenB Bosse
May 2, 2015·Drug Design, Development and Therapy·Wojciech Leppert

❮ Previous
Next ❯

Citations

Jun 6, 2018·The Cochrane Database of Systematic Reviews·Bridget CandyPatrick Stone
Jul 7, 2018·Expert Opinion on Pharmacotherapy·Shilan MozaffariMohammad Abdollahi
Jan 1, 2019·Journal of Gastroenterology and Hepatology·Kenichi NishieMasayuki Hanaoka
Nov 16, 2017·Nature Reviews. Gastroenterology & Hepatology·Eva SzigethyDouglas Drossman
Dec 22, 2017·Expert Opinion on Investigational Drugs·Shilan MozaffariMohammad Abdollahi
Feb 14, 2018·Clinical Medicine : Journal of the Royal College of Physicians of London·Angela Star, Jason W Boland
Nov 23, 2019·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·Jordi SerraUNKNOWN Functional Constipation Guidelines Working Group
Mar 21, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ferenc ZádorMahmoud Al-Khrasani
May 27, 2017·Current Pain and Headache Reports·O J Michael Coppes, Christine N Sang
Apr 22, 2020·Therapeutic Advances in Gastroenterology·Maite Casado-Bedmar, Åsa V Keita
Jul 18, 2017·Frontiers in Pharmacology·Hong Yang, Tonghui Ma
Sep 19, 2017·Journal of Pain and Symptom Management·Kannan Sridharan, Gowri Sivaramakrishnan
Apr 6, 2018·The American Journal of Medicine·Jose M Garcia, Tatyana A Shamliyan
May 6, 2019·Mayo Clinic Proceedings·Adil E Bharucha, Arnold Wald

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.